5 research outputs found

    Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice-7

    No full text
    Nsecutive days. On day 14 after PDT, the plates were fixed with methanol and stained with crystal violet.<p><b>Copyright information:</b></p><p>Taken from "Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice"</p><p>http://www.biomedcentral.com/1471-2407/8/197</p><p>BMC Cancer 2008;8():197-197.</p><p>Published online 11 Jul 2008</p><p>PMCID:PMC2478682.</p><p></p

    Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice-4

    No full text
    Cisplatin at a dose of 2.5, 5.0 or 7.5 mg/kg administered i.p. [A and B] or with cisplatin (5 mg/kg in a single i.p. injection) and 50 mg/kg of Zn(II)PPIX administered i.p. for 7 consecutive days [C and D]. Graphs show the influence of the treatment on the growth of melanoma in mice. *< 0.05 (two way Student's -test) in comparison with controls.<p><b>Copyright information:</b></p><p>Taken from "Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice"</p><p>http://www.biomedcentral.com/1471-2407/8/197</p><p>BMC Cancer 2008;8():197-197.</p><p>Published online 11 Jul 2008</p><p>PMCID:PMC2478682.</p><p></p

    Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice-6

    No full text
    Rystal violet staining assay. Bars represent means ± SD. *< 0.05 (two way Student's -test) in comparison with controls.<p><b>Copyright information:</b></p><p>Taken from "Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice"</p><p>http://www.biomedcentral.com/1471-2407/8/197</p><p>BMC Cancer 2008;8():197-197.</p><p>Published online 11 Jul 2008</p><p>PMCID:PMC2478682.</p><p></p

    Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice-0

    No full text
    Rystal violet staining assay. Bars represent means ± SD. *< 0.05 (two way Student's -test) in comparison with controls.<p><b>Copyright information:</b></p><p>Taken from "Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice"</p><p>http://www.biomedcentral.com/1471-2407/8/197</p><p>BMC Cancer 2008;8():197-197.</p><p>Published online 11 Jul 2008</p><p>PMCID:PMC2478682.</p><p></p

    Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice-8

    No full text
    Is using ethanol-fixed, propidium iodide-stained cells. [B and D] Western blotting for expression of cyclin D1, cleaved caspase 3 or tubulin as a loading control was performed. [C] Induction of apoptosis was evaluated by staining of cells with propidium iodide and annexin V. [E] HO-1 silencing was evaluated with Western blotting. Controls represent expression of HO-1 in hemin-treated C-26 cells. HuHO-1 siRNA is a negative control targeting xenogeneic (human) HO-1 gene, muHO-1 siRNA is a murine sequence that knocks-down HO-1 expression in C-26 cells. [F and G] production of reactive oxygen species was evaluated with flow cytometry by measuring CM-HDCFDA fluorescence in comparison with controls.<p><b>Copyright information:</b></p><p>Taken from "Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice"</p><p>http://www.biomedcentral.com/1471-2407/8/197</p><p>BMC Cancer 2008;8():197-197.</p><p>Published online 11 Jul 2008</p><p>PMCID:PMC2478682.</p><p></p
    corecore